Common Medical Emergencies - Cheat Sheet
Your final 30-minute rapid-fire reference for recognizing and managing acute respiratory, cardiac, allergic, hypertensive, abdominal, and diabetic emergencies. This sheet covers every high-yield point, critical drug dosages, treatment sequences, and exam-critical distinctions tested on the NLE and emergency nursing exams in the Philippines.
Acute Respiratory Emergencies
Common values
Value
>80 mmHg
Symbol
PaO2
Quantity
Normal PaO2 on room air
Value
<60 mmHg
Symbol
PaO2
Quantity
Critical PaO2 threshold
Value
35–45 mmHg
Symbol
PaCO2
Quantity
Normal PaCO2
Value
>50 mmHg
Symbol
PaCO2
Quantity
Respiratory failure PaCO2
Important facts
- Universal signs of respiratory failure: ↑ RR, ↑ work of breathing, use of accessory muscles, restlessness/anxiety (early hypoxia), cyanosis, ↓ O2 sat, ↓ consciousness
- PRIORITY positioning: High Fowler's (upright) to maximize lung expansion and reduce work of breathing
- Acute asthma attack mainstays: short-acting beta-2 agonists (salbutamol/albuterol), anticholinergics (ipratropium), systemic corticosteroids
- Continuous reassessment of O2 sat, work of breathing, mental status guides escalation to non-invasive ventilation or intubation
- Accessory muscle use = escalating severity; prepare for intubation if patient tires
- Stridor (barking cough) = upper airway obstruction; drooling/inability to swallow = impending airway loss
Key definitions
Respiratory Failure
Example
Patient with severe asthma exacerbation unable to maintain O2 sat >90% despite nebulizers.
Inability to maintain adequate oxygenation (PaO2 <60 mmHg on room air) or ventilation (PaCO2 >50 mmHg), representing a final common pathway for asthma, COPD, pneumonia, PE, and pulmonary edema.
Silent Chest
Example
Asthmatic presents with no audible wheeze on auscultation; this is an emergency, not reassurance.
Absence of air movement sounds (no wheezing) in a previously wheezing patient with asthma — ominous sign indicating severe airflow obstruction and impending respiratory arrest, NOT improvement.
Accessory Muscle Use
Example
Patient with COPD exacerbation retracting at suprasternal and intercostal spaces.
Recruitment of scalenes, sternocleidomastoids, and intercostal muscles (normal breathing uses diaphragm only); indicates increased work of breathing and respiratory distress.
Diagrams to know
- Respiratory distress progression: normal → tachypnea → accessory muscle use → silent chest → arrest
- Flow pattern in asthma: normal → wheezing → silent chest (obstruction too severe to move air)
Acute Coronary Syndrome (ACS) & Myocardial Infarction
Common values
Value
160–325 mg chewed
Symbol
ASA
Quantity
Aspirin loading dose
Value
0.3–0.6 mg, repeat q5 min × 3
Symbol
NTG
Quantity
Nitroglycerin SL dose
Value
2–4 mg IV, titrate q5–15 min
Symbol
Morphine
Quantity
Morphine initial dose
Value
<90 minutes
Symbol
D2B
Quantity
Door-to-PCI time target
Value
<30 minutes
Symbol
D2T
Quantity
Door-to-thrombolytic target
Value
3–4 hours post-MI (peaks 24–48 h)
Symbol
Tn
Quantity
Troponin detection window
Important facts
- Classic ACS: crushing substernal chest pain ± radiation to arm/jaw, diaphoresis, nausea, SOB
- 12-lead ECG within 10 minutes — mandatory; ECG changes guide diagnosis (ST elevation, ST depression, T-wave inversion, new LBBB)
- Troponin I or T elevation confirms myocardial injury; becomes detectable 3–4 hours post-infarction
- MONA components: Morphine (if pain unrelieved by nitrates), Oxygen (only if O2 sat <90%), Nitroglycerin (SL, repeat q5min), Aspirin (160–325 mg, chewed)
- CONTRAINDICATIONS to nitroglycerin: hypotension (SBP <90), RVI, PDE-5 inhibitor use (sildenafil, tadalafil) in past 24–48 hours
- Reperfusion therapy: ST elevation on ECG = urgent PCI (preferred) or fibrinolytic (if PCI unavailable); door-to-balloon <90 min, door-to-thrombolytic <30 min
- Continuous cardiac monitoring, IV access, serial troponins, and risk stratification essential
- Post-MI complications: arrhythmia, cardiogenic shock, pulmonary edema, mechanical rupture, VSD, free wall rupture
Key definitions
Acute Coronary Syndrome
Example
Patient with crushing substernal chest pain radiating to left arm + diaphoresis + nausea requires 12-lead ECG within 10 minutes.
Acute myocardial ischemia from coronary artery obstruction; includes unstable angina (pain without troponin rise) and MI (with troponin elevation); requires rapid reperfusion to limit infarction.
ST-Elevation MI (STEMI)
Example
ECG shows ST elevation in leads II, III, aVF (inferior STEMI); door-to-balloon time target <90 minutes.
Transmural MI with complete coronary artery occlusion; shows ST elevation ≥1 mm in contiguous leads on ECG; requires urgent reperfusion (PCI or fibrinolytics) — 'time is muscle.'
MONA Protocol
Example
Hypoxic patient: O2; non-hypoxic: skip O2; all: aspirin 160–325 mg chewed + nitroglycerin SL + morphine if pain unrelieved.
Mnemonic for ACS initial management: Morphine (pain), Oxygen (if hypoxic), Nitroglycerin (vasodilation), Aspirin (antiplatelet) — applied based on clinical indicators, not rigid order.
Right Ventricular Infarction (RVI)
Example
Inferior MI (ST elevation II, III, aVF) + RV involvement (ST elevation V4R); withhold nitrates, give fluids instead.
Infarction of the right ventricle (usually from RCA occlusion); characterized by hypotension with NORMAL or elevated JVP; nitroglycerin is contraindicated because RV depends on preload.
Atypical ACS Presentation
Example
Elderly diabetic woman presents with shortness of breath and fatigue only; troponin elevated → NSTEMI.
In women, older adults, and diabetics: chest pain may be absent or atypical (dyspnea, jaw/epigastric pain, extreme fatigue); delay in diagnosis increases mortality.
Diagrams to know
- Coronary artery anatomy: RCA (inferior wall, RV, AV node), LAD (anterior, septum, apex), LCx (lateral, posterior, SA node)
- ECG lead relationships to coronary territory: II/III/aVF (inferior/RCA), V1–V4 (anterior/LAD), V5–V6/I/aVL (lateral/LCx)
Acute Heart Failure & Pulmonary Edema
Common values
Value
40–80 mg (higher if chronic high doses)
Symbol
Lasix
Quantity
Furosemide IV initial dose
Value
0.3–0.6 mg SL or 5–10 mcg/min IV infusion, titrate
Symbol
NTG
Quantity
Nitroglycerin SL/IV dose
Value
<18 mmHg
Symbol
PAWP
Quantity
Normal PAWP
Value
>18 mmHg
Symbol
PAWP
Quantity
Pulmonary edema PAWP threshold
Important facts
- Classic triad of acute pulmonary edema: severe dyspnea + crackles + pink frothy sputum (or clear if mild)
- Associated signs: tachycardia, tachypnea, anxiety, diaphoresis, hypotension (cardiogenic shock) or hypertension
- PRIORITY nursing concept: 'Sit them up, dry them out, open them up'
- Position: HIGH FOWLER'S (upright) with legs dependent to reduce venous return and optimize ventilation
- Oxygen/NIPPV (CPAP/BiPAP): to improve oxygenation and reduce work of breathing
- IV loop diuretic (furosemide): mainstay of fluid offloading; onset 5–10 min IV; monitor urine output closely
- Vasodilators (nitroglycerin): reduce preload (venous dilation) and afterload (arterial dilation), improving cardiac output
- Monitor: O2 sat, BP, HR, breath sounds, urine output, weight, signs of cardiogenic shock
- Afterload reduction critical: IABP, inotropes if hypotensive; low BP limits diuretic and vasodilator use
Key definitions
Acute Decompensated Heart Failure
Example
Patient with history of MI presents acutely with severe dyspnea, PND, and crackles bilaterally — acute CHF exacerbation.
Sudden onset of dyspnea, orthopnea, and/or edema from inability of the heart to pump blood forward; results in pulmonary and/or systemic congestion.
Pulmonary Edema (Cardiogenic)
Example
Patient with acute CHF: dyspneic, orthopneic, profuse sweating, crackles throughout, pink frothy expectorate.
Acute flooding of the lungs with fluid from elevated pulmonary venous pressure; characterized by severe dyspnea, pink frothy sputum, crackles, and hypoxemia.
Orthopnea
Example
Patient must sleep on 3–4 pillows or in a chair to breathe; lying flat triggers dyspnea.
Dyspnea when lying flat due to increased venous return to the lungs; relieved by sitting upright; sign of elevated pulmonary venous pressure.
Diagrams to know
- Pathophysiology chain: LV dysfunction → ↑ LV end-diastolic pressure → ↑ pulmonary venous pressure → pulmonary edema
- Treatment priorities: position → oxygen/NIPPV → diuretics → vasodilators → monitor response
Anaphylaxis
Common values
Value
0.3–0.5 mg of 1:1000 solution
Symbol
Epi IM
Quantity
Epinephrine IM for anaphylaxis
Value
1 mg of 1:10,000 solution (NOT for anaphylaxis)
Symbol
Epi IV
Quantity
Epinephrine IV for cardiac arrest
Value
Every 5–15 minutes as needed
Symbol
Interval
Quantity
Repeat epinephrine interval
Value
25–50 mg IV/IM (adjunct only)
Symbol
Benadryl
Quantity
Diphenhydramine dose
Value
125 mg IV (adjunct for late-phase prevention)
Symbol
Solu-Medrol
Quantity
Corticosteroid (methylprednisolone)
Important facts
- SINGLE priority intervention: IM epinephrine FIRST — do NOT delay for adjuncts (antihistamines, steroids)
- Epinephrine dose for anaphylaxis: 0.3–0.5 mg IM of 1:1000 (0.3–0.5 mL), into anterolateral thigh (vastus lateralis)
- Repeat epinephrine every 5–15 minutes if no response (hypotension, continued dyspnea, stridor)
- CRITICAL DISTINCTION: Anaphylaxis ≠ cardiac arrest dosing — NOT 1 mg IV of 1:10,000 (that is for ACLS); confusing these is a dangerous error
- Adjuncts (secondary, never instead of epinephrine): high-flow O2, aggressive IV fluids for hypotension, antihistamines (diphenhydramine), corticosteroids
- Position: hypotensive patient supine with legs elevated; dyspneic patient more upright
- Airway management: anticipate rapid airway swelling; have equipment at bedside; intubate early if stridor or oropharyngeal swelling
- Watch for biphasic reaction — observe for ≥4–24 hours (some protocols); repeat epinephrine if symptoms recur
- Common triggers in Philippines: antibiotics (penicillins, cephalosporins), NSAIDs, contrast dye, foods (shellfish, peanuts), insect venom, latex
- Prevention: obtain detailed allergy history, use hypoallergenic gloves, have epinephrine auto-injector available for at-risk patients
Key definitions
Anaphylaxis
Example
Patient receives IV penicillin; within 2 minutes: urticaria, stridor, bronchospasm, hypotension, angioedema → anaphylaxis.
Rapidly progressive, life-threatening systemic allergic reaction from IgE-mediated mast cell degranulation; combines airway compromise, breathing difficulty, circulatory collapse, and skin/GI symptoms; onset typically within minutes of exposure.
Epinephrine (Adrenaline)
Example
0.3–0.5 mg IM 1:1000 (0.3–0.5 mL of 1:1000 solution) into anterolateral thigh; repeat q5–15 min as needed.
First-line, single priority drug for anaphylaxis; alpha-adrenergic (vasoconstriction) and beta-adrenergic (bronchodilation, reduced mediator release) agonist that reverses the reaction.
Biphasic Anaphylaxis
Example
Patient treated for anaphylaxis, improves; 4 hours later, hypotension and dyspnea recur despite no re-exposure.
Recurrence of anaphylactic symptoms hours after apparent recovery (typically 1–72 hours); occurs in 1–3% of cases; requires prolonged observation and repeat epinephrine dosing.
Angioedema
Example
Patient with anaphylaxis develops lip and tongue swelling; intubation becomes high priority if stridor develops.
Swelling of deep dermis and subcutaneous tissues (lips, tongue, pharynx, larynx); can progress to airway obstruction if not treated urgently.
Diagrams to know
- Anaphylaxis cascade: allergen exposure → IgE-mast cell crosslink → degranulation → histamine/tryptase/heparin/kinins/leukotrienes → systemic vasodilation, bronchoconstriction, angioedema
- ABCDE assessment in anaphylaxis: Airway (stridor, edema), Breathing (wheezing, dyspnea), Circulation (hypotension, shock), Disability (syncope, confusion), Exposure (rash, urticaria)
Hypertensive Crisis
Common values
Value
SBP >180 or DBP >120 mmHg
Symbol
BP criteria
Quantity
Hypertensive crisis threshold
Value
≤25% of baseline MAP in first hour
Symbol
Target reduction
Quantity
MAP reduction target
Value
20 mg initial, then 40–80 mg q10 min; max 220 mg
Symbol
Labetalol
Quantity
Labetalol IV dose
Value
5 mg/hr, titrate by 2.5 mg/hr q5–15 min; max 15 mg/hr
Symbol
Nicardipine
Quantity
Nicardipine IV infusion
Value
0.3–0.5 mcg/kg/min, titrate; max 10 mcg/kg/min (ICU only)
Symbol
SNP
Quantity
Sodium nitroprusside infusion
Value
70–100 mmHg
Symbol
MAP
Quantity
Normal MAP
Important facts
- KEY PRINCIPLE: lower BP gradually, NOT abruptly — rapid drops cause ischemic stroke, MI, or acute kidney injury from reduced perfusion
- Target: reduce Mean Arterial Pressure (MAP) by approximately ≤25% in the first hour (exception: aortic dissection, which needs faster control)
- MAP calculation: MAP = (SBP + 2×DBP) / 3; example: if SBP 200, DBP 120, MAP = (200 + 240)/3 = 147 mmHg
- First-line IV agents: labetalol (combined alpha/beta blocker), nicardipine (calcium channel blocker), sodium nitroprusside (direct vasodilator, requires ICU monitoring)
- Withhold or avoid: sudden nitroprusside boluses, immediate-release nifedipine (unpredictable drop), IV hydralazine monotherapy (causes reflex tachycardia)
- Hypertensive urgency: oral therapy (e.g., amlodipine, ACE inhibitor, diuretic) over hours, close follow-up
- Hypertensive emergency: admit to ICU, continuous IV infusion + arterial line BP monitoring, frequent neuro checks
- Monitor end-organs: check urine (proteinuria, RBCs), creatinine (acute renal injury), troponin (ACS), neurologic status q15–30 min
- Common causes: medication non-adherence, NSAID use, cocaine, sympathomimetics, renal disease, preeclampsia
- Aortic dissection special case: target SBP <120 and HR <60 (use labetalol then nitroprusside or nicardipine)
Key definitions
Hypertensive Crisis
Example
Patient with SBP 200 mmHg and DBP 130 mmHg; distinction is whether acute stroke, MI, pulmonary edema, or encephalopathy is present.
Severely elevated blood pressure (typically SBP >180 mmHg or DBP >120 mmHg); distinguished by presence or absence of acute target-organ damage.
Hypertensive Urgency
Example
Patient with known hypertension found with BP 190/125 but no headache, chest pain, dyspnea, or neuro changes → urgency, not emergency.
Severely elevated BP (SBP >180, DBP >120) WITHOUT acute target-organ damage; treated with oral antihypertensives over 24–48 hours; no emergency IV therapy needed.
Hypertensive Emergency
Example
Patient with BP 220/130 + severe headache, confusion, seizures (hypertensive encephalopathy) → emergency; requires IV antihypertensives.
Severely elevated BP WITH acute target-organ damage (encephalopathy, ACS, acute pulmonary edema, aortic dissection, AKI, acute stroke); requires controlled IV antihypertensive therapy.
Hypertensive Encephalopathy
Example
Patient with uncontrolled HTN, severe headache, confusion, seizure activity; MRI shows cerebral edema; treated with IV labetalol/nicardipine.
Acute cerebral dysfunction from severe hypertension causing cerebral edema; presents with headache, confusion, visual disturbances, seizures, altered consciousness; rapidly reversible with controlled pressure reduction.
Diagrams to know
- Autoregulation curve: cerebral blood flow maintained at MAP 50–150 mmHg; outside this range, ischemia (low) or edema (high) occurs
- Hypertensive crisis decision tree: SBP >180/DBP >120 → assess for target-organ damage (neuro, cardiac, renal, pulmonary) → urgency vs emergency → oral vs IV therapy
Reactions or equations
MAP = (SBP + 2×DBP) / 3
Note
For hypertensive emergency, calculate baseline MAP and target MAP (baseline MAP − 25% of baseline MAP); titrate IV antihypertensives to this target.
Conditions
Standard calculation for mean arterial pressure
Acute Abdomen
Common values
Value
Soft, non-tender, no rebound, no guarding, normal BS
Symbol
Normal
Quantity
Normal abdominal exam
Value
Rigid, board-like, rebound tenderness, guarding present
Symbol
Acute
Quantity
Acute abdomen indicator
Value
One-third distance from anterior superior iliac spine to umbilicus (classic appendicitis site)
Symbol
RLQ landmark
Quantity
McBurney's point location
Important facts
- Red flags: severe pain, rigid (board-like) abdomen, rebound tenderness, guarding, distension, hypotension, fever, elevated WBC
- PRIORITY nursing actions: keep NPO (nothing by mouth) for possible surgery, establish IV access, give IV fluids, assess pain continuously, prepare for diagnostics (CT, US, labs)
- CRITICAL — DO NOT apply heat, give laxatives/enemas, or use aggressive massage — these can rupture inflamed organs (e.g., appendix) and cause peritonitis
- Insert nasogastric tube if ordered for decompression in bowel obstruction; monitor NG output (character, volume)
- Avoid opioid analgesia only per protocol (some institutions allow judicious analgesia AFTER surgical evaluation) — do not mask the clinical picture inappropriately
- Bowel obstruction signs: severe crampy pain, vomiting, abdominal distension, high-pitched bowel sounds (early) or silent (late), visible peristaltic waves
- Ruptured AAA presentation: sudden severe abdominal/back pain, hypotension, pulsatile abdominal mass, shock — mortality high; requires immediate vascular surgery
- Ectopic pregnancy rupture: young woman with amenorrhea, sudden severe lower abdominal pain, shoulder pain, hemodynamic instability, ↓ Hgb
- Appendicitis: RLQ pain (often begins periumbilical then localizes), nausea, fever; McBurney's point tenderness, rebound > direct tenderness (McBurney's is more painful)
- Monitor vital signs closely; shock (hypotension, tachycardia, altered mental status) indicates need for emergency surgery
Key definitions
Acute Abdomen
Example
Patient with sudden severe epigastric pain, rigid abdomen, hypotension → ruptured peptic ulcer or AAA; requires urgent surgical consultation.
Sudden onset of severe abdominal pain potentially indicating a surgical emergency; includes appendicitis, perforation (peptic ulcer, viscus), bowel obstruction, mesenteric ischemia, ruptured ectopic pregnancy, and ruptured AAA.
Peritonitis
Example
Perforated appendix leads to peritonitis: severe pain, fever, rigid board-like abdomen, hypotension, tachycardia.
Inflammation/infection of the peritoneum; presents with severe abdominal pain, rigidity, guarding, rebound tenderness, fever, elevated WBC; can progress to septic shock and death if untreated.
Rebound Tenderness
Example
Examiner presses RLQ, patient tolerates; on sudden release, patient winces in pain — positive rebound tenderness.
Sharp pain on rapid release of palpating hand (pain is worse when letting go than when pressing); indicates peritoneal irritation and visceral perforation.
Guarding
Example
Rigid, board-like abdomen that does not relax even with deep breathing; indicates serious pathology requiring urgent evaluation.
Involuntary contraction of abdominal wall muscles during palpation; sign of peritoneal irritation; distinguishes from voluntary guarding (patient tenses muscles).
Diagrams to know
- Acute abdomen assessment: pain character/location → peritoneal signs (rebound, guarding, rigidity) → organ-specific signs → imaging/labs → surgical consult
- Bowel obstruction chain: mechanical block → proximal bowel dilation → vomiting → dehydration → shock → perforation/peritonitis
Hypoglycemia
Common values
Value
<70 mg/dL (3.9 mmol/L)
Symbol
BG
Quantity
Hypoglycemia threshold
Value
15 g fast-acting carbohydrate
Symbol
Carbs
Quantity
Rule of 15 carb dose
Value
15 minutes
Symbol
Time
Quantity
Rule of 15 recheck interval
Value
25 g (50 mL of D50)
Symbol
Dextrose
Quantity
IV dextrose 50% dose
Value
1 mg (0.3–1 mg); onset 5–15 min
Symbol
Glucagon
Quantity
IM glucagon dose
Important facts
- Hypoglycemia is MORE immediately dangerous than hyperglycemia — brain dies within minutes of severe glucose deficit
- Rapid onset distinguishes hypoglycemia from DKA/HHS (which are gradual, hours to days)
- Early signs: adrenergic (tremor, diaphoresis, palpitations, anxiety, hunger) — patient usually still alert and able to communicate
- Late signs: neuroglycopenic (confusion, slurred speech, altered behavior, seizures, coma) — patient at risk of injury
- CRITICAL: NEVER give oral carbohydrate to unconscious or unalert patient — aspiration risk is fatal; use IV dextrose or IM glucagon
- Conscious patient protocol (Rule of 15): 15 g fast-acting carbs (glucose tablets, juice, hard candy, honey) → wait 15 min → recheck → repeat if <70 → then complex carb (bread, crackers, protein)
- Unconscious/unable-to-swallow protocol: IV dextrose 25 g (50 mL of D50) or IM glucagon 1 mg (onset 5–15 min, lasts 60–90 min); follow with oral carbs when alert
- Glucagon is less effective in depleted glycogen stores (starvation, ethanol abuse); if no response to first dose, use IV dextrose
- After hypoglycemia episode: review cause (missed meal, overdose, excessive exercise), adjust diet or insulin dose, educate on prevention
- Patient should carry glucose source at all times; wear medical alert identification; teach family to recognize and treat hypoglycemia
Key definitions
Hypoglycemia
Example
Diabetic patient on insulin misses lunch; develops shakiness, sweating, confusion within 30 minutes.
Blood glucose <70 mg/dL (3.9 mmol/L); acute onset (minutes) from insulin excess, missed meals, or strenuous exercise; brain is glucose-starved and symptomatic.
Adrenergic Symptoms
Example
Patient feels shaky, sweaty, heart racing, hungry — classic adrenergic response to low blood glucose.
Early signs of hypoglycemia from sympathetic nervous system activation: tremor, sweating, tachycardia, palpitations, anxiety, hunger.
Neuroglycopenic Symptoms
Example
Diabetic patient found confused, combative, slurred speech, no response to commands — severe neuroglycopenia.
Later signs of hypoglycemia from direct brain glucose deprivation: confusion, irritability, slurred speech, altered behavior, seizures, loss of consciousness.
Rule of 15
Example
Glucose 55 mg/dL: give 15 g glucose tablets or juice, recheck in 15 min; if still <70, repeat; once >70, eat crackers/bread to sustain.
Hypoglycemia treatment protocol for conscious patient: give 15 g fast-acting carbohydrate, wait 15 minutes, recheck glucose; repeat if still low; then give complex carb to prevent recurrence.
Diagrams to know
- Hypoglycemia symptom progression: normal → adrenergic (tremor, sweat) → neuroglycopenic (confusion) → seizure → coma → death
- Hypoglycemia treatment algorithm: conscious & alert → Rule of 15 (oral carbs) vs unconscious/altered → IV dextrose or IM glucagon
Diabetic Ketoacidosis (DKA)
Common values
Value
>250 mg/dL (often 300–600)
Symbol
BG
Quantity
DKA diagnostic BG
Value
<7.3 (severe <7.1)
Symbol
pH
Quantity
DKA diagnostic pH
Value
<15 mEq/L (severe <10)
Symbol
HCO3
Quantity
DKA diagnostic HCO3
Value
1 L in first hour, then 0.5 L/hr for first 4 hr, then 0.25 L/hr
Symbol
Fluids
Quantity
IV normal saline rate
Value
0.05–0.1 units/kg/hr; target BG drop 50–75 mg/dL/hr
Symbol
Insulin
Quantity
IV regular insulin infusion
Value
If K+ <5.5 mEq/L, add KCl 20–40 mEq/L to IV fluids after urine output confirmed
Symbol
K+ replacement
Quantity
Potassium replacement threshold
Value
Add D5 or D10 when BG reaches 200–250 mg/dL
Symbol
Dextrose trigger
Quantity
Dextrose switch glucose
Value
>600 mg/dL (often 800–1200)
Symbol
BG HHS
Quantity
HHS diagnostic BG
Value
>320 mOsm/kg
Symbol
Osmolality
Quantity
HHS osmolality
Important facts
- DKA onset is GRADUAL (hours to days) — distinguishes it from rapid-onset hypoglycemia
- Classic DKA triad: hyperglycemia (BG >250 mg/dL, often 300–600), metabolic acidosis (pH <7.3, HCO3 <15), positive serum and urine ketones
- Classic presentation: polydipsia, polyuria, nausea, abdominal pain, Kussmaul respirations, fruity/acetone breath odor, altered consciousness
- Total-body potassium is DEPLETED in DKA despite normal serum K+ — insulin shifts K+ into cells, causing dangerous hypokalemia as treatment begins
- PRIORITY management sequence: (1) FLUIDS FIRST — aggressive IV normal saline to correct severe volume deficit (often 5–10 L); (2) INSULIN — IV regular insulin infusion (not bolus) to shut off ketogenesis; (3) POTASSIUM — monitor K+ closely, replace if <5.5 mEq/L before starting insulin, then add to IV fluids once insulin is infusing
- DO NOT start insulin if serum K+ is severely low (<3.0 mEq/L) — will cause cardiac arrhythmias; replace K+ first
- Add dextrose (D5 or D10) to IV fluids once glucose falls to 200–250 mg/dL to prevent hypoglycemia while acidosis resolves
- Insulin dose: 0.05–0.1 units/kg/hr IV infusion; titrate to lower BG by 50–75 mg/dL/hr (not faster)
- Monitor: BG q1h, VBG/ABG for pH/HCO3, electrolytes (especially K+) q2–4h initially, urine output, mental status, signs of cerebral edema
- Cerebral edema risk: young patients, severe acidosis, rapid correction — manifests as altered consciousness, seizures; mortality >50% if occurs
- Precipitants: missed insulin, infection (UTI, pneumonia), MI, new-onset diabetes, stress; always investigate cause
- HHS management identical to DKA (fluids → insulin → K+) but mortality higher due to severe dehydration and older age; slower glucose correction needed
Key definitions
Diabetic Ketoacidosis
Example
Type 1 diabetic forgets insulin; presents with BG 450 mg/dL, pH 7.15, HCO3 10, positive ketones, Kussmaul respirations.
Life-threatening hyperglycemic emergency, mostly in type 1 diabetes; caused by absolute or relative insulin deficiency → fat breakdown → ketoacid accumulation → metabolic acidosis (pH <7.3, HCO3 <15 mEq/L).
Ketoacidosis
Example
Insulin-deficient patient: lipolysis → free fatty acids → ketone production → ↑ ketones in blood → acidosis.
Metabolic acidosis from accumulation of ketoacid anions (beta-hydroxybutyrate, acetoacetate) in blood; lowers pH and HCO3.
Kussmaul Respirations
Example
DKA patient breathing deeply and rapidly (RR 30+) even at rest; fruity/acetone smell on breath.
Deep, rapid, labored breathing (apparent hyperventilation) as respiratory compensation for metabolic acidosis; patient attempts to blow off CO2 to raise pH.
Osmotic Diuresis
Example
DKA patient: polyuria (frequent urination), polydipsia (excessive thirst), profound dehydration, orthostatic hypotension.
Glycosuria (glucose in urine) because glomerular filtration exceeds renal reabsorption threshold; glucose acts as osmotic diuretic → polyuria, polydipsia, severe dehydration.
Hyperosmolar Hyperglycemic State (HHS)
Example
Type 2 diabetic, elderly, presents with BG 800 mg/dL, normal pH, minimal ketones, severely dehydrated.
Hyperglycemic emergency in type 2 diabetes; extreme hyperglycemia (often >600 mg/dL) with severe dehydration, minimal/absent ketosis, and hyperosmolarity; mortality higher than DKA.
Diagrams to know
- DKA pathophysiology: insulin deficiency → gluconeogenesis, lipolysis → ↑ BG, ↑ ketones → metabolic acidosis → Kussmaul respirations → osmotic diuresis → severe dehydration → shock
- DKA management flowchart: fluids → lab assessment (BG, K+, HCO3, pH) → start insulin (after K+ >3.0) → add dextrose when BG 200–250 → monitor q1–2h → resolution when pH >7.3, HCO3 >15, patient eating
Must remember
Critical point
SILENT CHEST IN ASTHMATIC = OMINOUS SIGN OF IMPENDING RESPIRATORY ARREST, NOT IMPROVEMENT. Absence of wheeze means obstruction is so severe that air cannot move; patient is critically ill and needs immediate intubation preparation.
Critical point
ANAPHYLAXIS EPINEPHRINE: 0.3–0.5 mg IM (1:1000) into thigh; CARDIAC ARREST EPINEPHRINE: 1 mg IV (1:10,000). CONFUSING THESE IS A DANGEROUS ERROR. Anaphylaxis is IM first-line; cardiac arrest is IV.
Critical point
ACUTE CORONARY SYNDROME: 12-LEAD ECG WITHIN 10 MINUTES is mandatory. MONA (Morphine, Oxygen if hypoxic, Nitroglycerin, chewed Aspirin 160–325 mg). WITHHOLD NITRATES IF: hypotensive (SBP <90), RV infarction, or PDE-5 inhibitor use (sildenafil, tadalafil) in past 24–48 hours.
Critical point
ACUTE PULMONARY EDEMA PRIORITY: SIT THEM UP (high Fowler's), OXYGEN/NIPPV, GIVE IV FUROSEMIDE, GIVE VASODILATORS (nitroglycerin). This sequence directly reverses the pathophysiology.
Critical point
HYPERTENSIVE EMERGENCY PRINCIPLE: LOWER BP GRADUALLY (≤25% MAP reduction in first hour), NEVER ABRUPTLY. Rapid pressure drops cause ischemic stroke, MI, or AKI from reduced organ perfusion. Requires ICU monitoring with arterial line.
Critical point
HYPOGLYCEMIA IS MORE IMMEDIATELY DANGEROUS THAN HYPERGLYCEMIA. Rapid onset (minutes); brain dies from glucose deprivation. RULE OF 15 for conscious patients: 15 g fast carbs → wait 15 min → recheck → repeat if low → then complex carb. NEVER oral carbs if unconscious (aspiration).
Critical point
DKA MANAGEMENT SEQUENCE: (1) FLUIDS FIRST (aggressive IV normal saline), (2) INSULIN (IV regular infusion, NOT bolus), (3) POTASSIUM (monitor closely; total body K+ is depleted; do NOT start insulin if K+ <3.0). Onset is GRADUAL (hours–days), not rapid.
Critical point
ACUTE ABDOMEN CRITICAL DO-NOTs: NO HEAT, NO LAXATIVES, NO ENEMAS — these can rupture inflamed organs (appendix) and cause peritonitis. Keep NPO for possible surgery; establish IV access; monitor pain and vitals; prepare for urgent imaging/consult.
Critical point
ANAPHYLAXIS: EPINEPHRINE IS THE SINGLE PRIORITY DRUG. Give IM immediately — do NOT delay for antihistamines or steroids (these are adjuncts only). Watch for BIPHASIC REACTION (recurrence hours later); observe for ≥4–24 hours; anticipate airway swelling.
Critical point
DIABETIC EMERGENCIES DISTINCTION: HYPOGLYCEMIA (rapid, <70 mg/dL, adrenergic/neuroglycopenic symptoms) vs. DKA (gradual, BG >250, acidosis, Kussmaul respirations, fruity breath) vs. HHS (gradual, BG >600, type 2, severe dehydration, minimal ketosis). Treatment pathways differ completely.
Last minute tips
Tip text
For any chest pain or ACS suspicion: 12-LEAD ECG WITHIN 10 MINUTES. This single test determines if the patient needs urgent reperfusion (PCI or fibrinolytics). Delays in ECG = delays in life-saving therapy. Mark the time on the ECG.
Tip title
ECG Timing in ACS
Tip text
MEMORIZE: Anaphylaxis = 0.3–0.5 mg IM of 1:1000 epinephrine (0.3–0.5 mL). Cardiac arrest = 1 mg IV of 1:10,000 (10 mL). These are tested frequently and confusion is dangerous. Use mnemonics: 'Thigh is 1:1000' (anaphylaxis, IM), 'Vein is 1:10,000' (arrest, IV).
Tip title
Anaphylaxis Dosing: Write It Down
Tip text
For conscious diabetic with hypoglycemia: RULE OF 15 is gold standard on NLE exams. 15 g carbs → 15 min wait → recheck → repeat if <70 → then complex carb. If unconscious: IV dextrose or IM glucagon (NEVER oral). This distinction is tested frequently.
Tip title
Rule of 15 for Hypoglycemia
Tip text
When a patient presents with acute severe abdominal pain: (1) assess peritoneal signs (rebound, guarding, rigidity), (2) keep NPO immediately, (3) establish IV, (4) do NOT apply heat/laxatives/enemas, (5) notify physician/surgeon stat. Do not delay imaging or surgical consult waiting for 'perfect' diagnosis.
Tip title
Acute Abdomen Assessment Sequence
Tip text
MAP = (SBP + 2×DBP) / 3. For hypertensive emergency with IV antihypertensives, calculate baseline MAP and reduce by ≤25% in first hour. This prevents over-correction. Example: Baseline MAP 147 → target MAP drop to 110. Arterial line monitoring is essential for accurate, continuous BP measurement.
Tip title
Hypertensive Emergency: Know MAP Math
Comparison tables
Hypoglycemia vs. Diabetic Ketoacidosis (DKA) vs. Hyperosmolar Hyperglycemic State (HHS)
| Feature | Hypoglycemia | DKA | HHS |
|---|---|---|---|
| Type of diabetes | Type 1 or 2 (on insulin/sulfonylurea) | Type 1 (absolute insulin deficit) | Type 2 (relative insulin deficit) |
| Blood glucose | <70 mg/dL | 250–600 mg/dL (usually >250) | >600 mg/dL (often 800–1200) |
| Onset | RAPID (minutes) | GRADUAL (hours–days) | GRADUAL (days–weeks) |
| pH/HCO3 | Normal | <7.3, HCO3 <15 (acidosis) | Normal or slightly ↓ (no ketosis) |
| Ketones | Negative or trace | Strongly positive (serum & urine) | Negative or trace |
| Kussmaul respirations | No | YES (characteristic) | No (but tachypnea) |
| Breath odor | Normal | Fruity/acetone (ketones) | Normal |
| Key symptoms | Tremor, sweating, anxiety, confusion, seizures, coma | Polydipsia, polyuria, N/V, abdominal pain, altered mental status | Severe dehydration, altered mental status, weakness |
| Mortality | High if prolonged/severe | 1–5% with treatment | 5–15% (higher than DKA) |
| PRIORITY treatment | Fast-acting carbs (Rule of 15) or IV dextrose/IM glucagon | Fluids → Insulin → Potassium | Fluids → Insulin → Potassium (same as DKA) |
| Critical danger | Brain starved within minutes; seizures, coma, death | Cerebral edema risk; metabolic acidosis; shock | Severe dehydration; osmotic complications; stroke/MI risk |
Acute Coronary Syndrome (ACS) Presentation & Interventions
| Aspect | Classic Presentation | Atypical Presentation (Women/Elderly/Diabetic) | MONA Intervention |
|---|---|---|---|
| Chest pain | Crushing substernal, radiates arm/jaw | May be absent or atypical (dyspnea, jaw pain, epigastric discomfort) | — |
| Associated symptoms | Diaphoresis, nausea, SOB, anxiety | Extreme fatigue, weakness, SOB only | — |
| Mortality risk | Standard | HIGHER (delayed diagnosis) | — |
| Morphine use | If pain persists after NTG | Same; may mask atypical presentation | 2–4 mg IV, titrate q5–15 min |
| Oxygen use | Only if SpO2 <90% | Only if SpO2 <90% | Only if hypoxic (no benefit if normoxic) |
| Nitroglycerin use | 0.3–0.6 mg SL, repeat q5 min | Same | 0.3–0.6 mg SL; AVOID if RVI, hypotensive, or PDE-5 inhibitor use |
| Aspirin use | 160–325 mg chewed ASAP | Same | Chewed (faster absorption than swallowed) |
Anaphylaxis vs. Cardiac Arrest: Epinephrine Dosing (CRITICAL)
| Criterion | Anaphylaxis | Cardiac Arrest (ACLS) |
|---|---|---|
| Drug | Epinephrine (adrenaline) | Epinephrine (adrenaline) |
| Concentration | 1:1000 (1 mg/mL) | 1:10,000 (0.1 mg/mL) |
| Route | INTRAMUSCULAR (IM) into anterolateral thigh | INTRAVENOUS (IV) |
| Dose | 0.3–0.5 mg IM (0.3–0.5 mL of 1:1000) | 1 mg IV (10 mL of 1:10,000) |
| Repeat interval | Every 5–15 minutes as needed | Every 3–5 minutes (cardiac arrest protocol) |
| Priority timing | FIRST intervention — do NOT delay | After airway/breathing established |
| CRITICAL ERROR | CONFUSING with cardiac arrest dose = DANGEROUS ERROR; will cause overdose or underdose | CONFUSING with anaphylaxis dose = DANGEROUS ERROR; will cause overdose or underdose |
Hypertensive Urgency vs. Hypertensive Emergency
| Feature | Hypertensive Urgency | Hypertensive Emergency |
|---|---|---|
| BP level | SBP >180 or DBP >120 mmHg | SBP >180 or DBP >120 mmHg |
| Target-organ damage | ABSENT — no acute neuro, cardiac, renal, or pulmonary damage | PRESENT — acute stroke, MI, pulmonary edema, encephalopathy, AKI |
| Treatment setting | Outpatient or ED observation; no ICU required | ICU admission mandatory |
| Therapy type | ORAL antihypertensives (amlodipine, ACE-I, diuretic) | IV antihypertensive infusion (labetalol, nicardipine, nitroprusside) |
| Time frame | Lower BP over 24–48 hours; gradual reduction | Controlled reduction; target ≤25% MAP decrease in 1st hour |
| Monitoring | Standard: BP check q1–4h | Continuous: arterial line, frequent neuro checks q15–30 min |
| Risk of rapid drop | Low — less aggressive therapy | HIGH — can cause ischemic stroke, MI, AKI if over-corrected |
| Example | Known HTN, BP 190/125, no symptoms → take to urgent care, start oral meds | BP 220/130 + severe headache + seizures (encephalopathy) → ICU, IV antihypertensives, arterial line |
Respiratory Distress Progression & Recognition
| Stage | Signs & Symptoms | Work of Breathing | Mental Status | PRIORITY Intervention |
|---|---|---|---|---|
| Early dyspnea | SOB with exertion, tachypnea (RR 20–24), able to speak in full sentences | Mild increase; diaphragm working | Alert, cooperative | Oxygen, upright positioning, assess cause |
| Moderate distress | SOB at rest, tachypnea (RR 25–40), nasal flaring, able to speak short phrases only | Moderate increase; accessory muscles engaged (intercostal, suprasternal retractions) | Alert but anxious | High-flow oxygen, prepare for NIPPV (CPAP/BiPAP), nebulizer, labs |
| Severe distress | Severe SOB, tachypnea (RR >40), stridor or wheeze, cannot speak (only words) | Severe; accessory muscles + diaphragmatic fatigue; tripod positioning | Anxious, restless, early hypoxia confusion | High-flow O2, NIPPV or prepare for intubation, IV access, medication boluses |
| Respiratory fatigue/impending arrest | SILENT CHEST (no air movement), RR ↓ (patient tiring), cyanosis, decreased response | DECREASED work — this is BAD (not good), muscle fatigue | Confused, drowsy, decreased consciousness | IMMEDIATE intubation, bag-valve-mask ventilation, epinephrine, ACLS protocol |
Diagrams
Common Medical Emergencies: Recognition & Priority Interventions
Rapid triage flowchart for recognizing common medical emergencies and initiating priority interventions. This diagram guides the initial assessment (ABCs, vital signs) and branches to specific emergency types with their corresponding first-line management.
Anaphylaxis: Drug Dosing & Management Priority
Mind map organizing anaphylaxis management with emphasis on epinephrine as the single priority drug, critical dosing distinctions from cardiac arrest, vital supportive actions, and common errors that could appear on NLE exams.
Diabetic Emergencies: Rapid Differentiation & Treatment
Flowchart for rapid differentiation of hypoglycemia (rapid onset, low glucose), DKA (gradual onset, acidosis, ketones, Kussmaul respirations), and HHS (gradual, type 2, no ketones). Each branch shows critical treatment sequence and key diagnostic findings tested on NLE.
Acute Coronary Syndrome: ECG, MONA, & Reperfusion
Flowchart for ACS management emphasizing mandatory 12-lead ECG within 10 minutes, MONA protocol with critical contraindications (RVI, hypotension, PDE5 inhibitors), and rapid reperfusion therapy decision tree. This is high-yield for NLE exams.
Respiratory Distress Progression to Arrest
State diagram showing progression from normal breathing through early distress, moderate distress, severe distress, respiratory fatigue (silent chest = ominous), and arrest. Highlights critical interventions at each stage and emphasizes that silent chest indicates fatigue and imminent arrest—not improvement.